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Background: Mesenchymal stem cell transplantation is a promising method in regenerative 
medicine. Gene-modified mesenchymal stem cells possess superior characteristics of specific 
tissue differentiation, resistance to apoptosis, and directional migration. Viral vectors have the 
disadvantages of potential immunogenicity, carcinogenicity, and complicated synthetic 
  procedures. Polyethylene glycol-grafted polyethylenimine (PEG-PEI) holds promise in gene 
delivery because of easy preparation and potentially targeting modification.
Methods: A PEG8k-PEI25k graft copolymer was synthesized. Agarose gel retardation 
assay and dynamic light scattering were used to determine the properties of the nanoparticles. 
MTT reduction, wound and healing, and differentiation assays were used to test the cytobio-
logical characteristics of rat mesenchymal stem cells, fluorescence microscopy and flow 
cytometry were used to determine transfection efficiency, and atomic force microscopy was 
used to evaluate the interaction between PEG-PEI/plasmid nanoparticles and mesenchymal 
stem cells.
Results: After incubation with the copolymer, the bionomics of mesenchymal stem cells showed 
no significant change. The mesenchymal stem cells still maintained high viability, resettled the 
wound area, and differentiated into adipocytes and osteoblasts. The PEG-PEI completely packed 
plasmid and condensed plasmid into stable nanoparticles of 100–150 nm diameter. After opti-
mizing the N/P ratio, the PEG-PEI/plasmid microcapsules delivered plasmid into mesenchymal 
stem cells and obtained an optimum transfection efficiency of 15%–21%, which was higher 
than for cationic liposomes.
Conclusion: These data indicate that PEG-PEI is a valid gene delivery agent and has better 
transfection efficiency than cationic liposomes in mesenchymal stem cells.
Keywords: stem cells, gene delivery, nanoparticles, atomic force microscopy
Introduction
Stem cells are clonal precursors of nonhematopoietic tissue, and possess the capability 
of self-renewal and differentiation into various tissue cells, such as osteoblasts,1 
chondrocytes,2 astrocytes,3 neurons,4 and adipocytes.5 Among several categories of 
stem cells, mesenchymal stem cells are used widely in regenerative medicine because 
of their multilineage differentiation,6 secretion of many cytokines and trophic factors,7 
low immunogenicity,8 and freedom from ethical controversy. Mesenchymal stem cells 
can be safely introduced into the brain, migrate directionally towards injured tissue, 
and can promote functional recovery.9 Transplanted mesenchymal stem cells are cur-
rently under intensive investigation in regenerative medicine as potential cell-based 
therapies for neurological diseases or injuries.10 Gene-modified mesenchymal stem International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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cells possess superior characteristics of specific tissue 
differentiation,11 resistance to apoptosis,12 and directional 
migration.13
Viral gene delivery vectors, such as retroviruses, adeno-
viruses, and adeno-associated viruses, are extensively used 
for gene delivery and show superior transfection efficiency.14,15 
However, viral vectors have shown the disadvantages of 
potential immunogenicity and carcinogenicity, and have a 
complicated synthesis procedure. Recently, nonviral gene 
vectors, including liposomes and cationic polymers, have 
received great attention because of their easy preparation, 
lack of immunogenicity, and ability to be modified for poten-
tial targeted delivery.16–18 Among the cationic polymers, 
polyethylenimine was reported to be an effective transfection 
reagent due to easy synthesis and multiple modifications.19,20 
Polyethylenimine concentrates negatively charge DNA via 
electrostatic interaction and form polyethylenimine/DNA 
nanoparticles. They enter nuclei through several steps, 
including cellular uptake, escaping from nucleases, endo-
somal release, and DNA decondensation inside nuclei.21
However, excessive usage of polyethylenimine results in 
high cytotoxicity, which is the major limitation in polyeth-
ylenimine-mediated gene delivery.22 Furthermore, serum-free 
culture media is preferred in transfection experiments in vitro 
to avoid the interaction between polyethylenimine and serum 
protein. In addition, serum deprivation could induce apop-
tosis of mesenchymal stem cells.23 Therefore, covalent link-
age with nonionic and hydrophilic polymers, such as 
polyethylene glycol, has been used to minimize the toxicity 
of polyethylenimine.24–26 Polyethylene glycol has also 
improved the solubility of polyethylene glycol-grafted poly-
ethylenimine (PEG-PEI) complexes, minimized aggregation, 
and reduced nonspecific interactions with proteins in physi-
ological fluids.27–29
To our knowledge, there are few studies reported on the 
use of PEG-PEI to prepare PEG-PEI/DNA nanoparticles for 
gene delivery into mesenchymal stem cells. In this work, 
PEG-PEI was synthesized, and its toxicity and biocompatibil-
ity were evaluated by MTT, wound and healing, and cell 
differentiation assays using mesenchymal stem cells. 
Plasmid-encapsulated PEG-PEI (PEG-PEI/plasmid) nano-
particles were prepared, and their properties were investi-
gated by agarose gel retardation assay and dynamic light 
scattering analysis. The gene transfection efficiency was 
assessed by inverted fluorescence microscopy and flow 
cytometry. The interaction between plasmid-encapsulated 
PEG-PEI nanoparticles and rat mesenchymal stem cells was 
studied by atomic force microscopy.
Materials and methods
Materials
Polyethylenimine with a molecular weight of 25 kDa 
was bought from Sigma-Aldrich (St Louis, MO). 3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) and Dulbecco’s modified Eagle’s medium/F-12 
(DMEM) were obtained from Gibco (Gibco, Carlsbad, CA). 
Adipogenic and osteogenic media were bought from 
  Cyagen Biosciences, China. PureYieldTM Plasmid Midi Prep 
System was bought from Promega (Madison, WI). 
  Lipofectamine™ was bought from Beyotime Institute of 
Biotechnology, China.
synthesis and characterization  
of Peg8k-PeI25k
Methoxy N-hydroxysuccinimide polyethylene glycol 
(mPEG2k-NHS) was synthesized according to our previous 
work.30 PEG8k-PEI25k was synthesized by adding 1.25 g of 
hyperbranched polyethylenimine and 0.5 g of mPEG-NHS 
to phosphate-buffered saline (pH 7.4), and the solution was 
magnetically stirred at room temperature overnight. 
The resulting solution was purified by membrane dialysis 
(molecular weight cutoff 3.5 kDa) in distilled water for 
48 hours, and then lyophilized to obtain PEG8k-PEI25k. 
PEG-PEI was characterized by 1H-NMR (Varian Mercury 
300-mHz NMR spectrometer, Mountain View, CA) in deu-
terium oxide. Fourier transform infrared measurement was 
carried out using a Fourier transform infrared analyzer 
(Nicolet/Nexus 670, Woodland, CA) at a resolution of 4 cm-1 
using the KBr method.
Preparation and properties of plasmid-
encapsulated Peg-PeI nanoparticles
Preparation
The plasmid-enhanced green fluorescent protein (pEGFP-C1, 
4.7 kb) was expanded in Escherichia coli (E. coli strain 
DH5α) and purified with the Plasmid Midi Prep System 
following the manufacturer’s protocol. The quantity and 
quality of the purified plasmid were assessed by optical 
density at 260 nm and 280 nm, and by electrophoresis in 
0.8% agarose gel. The purified plasmid was resuspended in 
ultrapure water and kept in aliquots at a concentration of 
0.7 mg/mL. The plasmid solution, and the desired amount 
of PEG-PEI solution in accord with the required N/P ratio 
(molar ratio of the positive amino groups of polyethylenimine 
to the phosphoric anions of plasmid) were separately diluted 
with 0.9% NaCl to 100 µL. The copolymer solution was then International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
845
Peg-grafted polyethylenimine nanoparticles
added to the plasmid solution and mixed by incubating at 
200 rpm at room temperature for 30 minutes. The com-
plexes obtained were kept standing at room temperature 
for 30 minutes before use.
Agarose gel retardation assay
To condense 1 µg of plasmid, the plasmid-encapsulated 
PEG-PEI complexes were prepared at designated N/P ratios 
of 0, 0.5, 1, 1.5, 2, 2.5, 3, and 4 without dilution. Loading 
buffer was added to the samples. The samples were loaded 
onto 0.8% agarose gel stained with 3 µL ethidium bromide 
solution (10 µg/µL), and electrophoresed at 90 V for 
45 minutes. An ultraviolet image station (Olympus, Japan) 
was used to record the gel images.
Dynamic light scattering analysis
To condense 1 µg of plasmid, plasmid-encapsulated   PEG-PEI 
was prepared at designated N/P ratios of 0, 0.5, 1, 1.5, 2, 2.5, 
3, 4, 5, 7, 10, 15, 20, 25, and 30. The plasmid solution and 
the desired amount of PEG-PEI solution in accord with the 
required N/P ratio were separately diluted with ultrapure 
water to 100 µL. The copolymer solution was then added to 
the plasmid solution and mixed by incubation at 200 rpm 
and room temperature for 30 minutes in order to form 
complexes. The size of the nanoparticles was determined by 
a Zetasizer 3000HS (Malvern, UK) at specified time intervals 
at room temperature. Samples were run in triplicate.
Cytobiological assessment of rat 
mesenchymal stem cells
Cell culture
The rat mesenchymal stem cells were harvested from the 
femurs and tibias of four-week-old (about 60 g) female 
Sprague-Dawley rats (Center of Experimental Animal of Sun 
Yat-sen University, Guangzhou). The rats were sacrificed by 
cervical dislocation. Briefly, the bones were excised asepti-
cally from the hind limbs of rats and placed in high-glucose 
DMEM after removing the parenchyma. After the knee joint 
end of each bone was removed using sterile scissors to create 
a hole, the bone marrow was flushed from the shaft with 
DMEM using a 26 gauge needle. The marrow solution was 
harvested by 5000 rpm centrifugation and aspiration of the 
supernatant, then the precipitate was resuspended in DMEM 
(supplemented with 10% fetal bovine serum, 2 mM glu-
tamine, 100 U/mL penicillin, and 100 g/mL streptomycin), 
and seeded into two 25 cm tissue culture flasks. After 
36 hours, the flasks were rinsed three times with phosphate-
buffered saline to remove the nonadherent cells. The medium 
was exchanged every three days throughout the studies. 
Twenty-four hours before the transfection experiments, 
adherent cells were rinsed with phosphate-buffered saline, 
trypsinized, and seeded in 24-well plates with complete 
DMEM without antibiotics. Cells were incubated at 37°C in 
a fully humidified atmosphere of 5% CO2.
MTT assay
The rat mesenchymal stem cells were seeded in 96-well 
plates at an initial density of 5000 cells/well in 200 µL of 
complete DMEM and cultured for 24 hours prior to adding 
PEG-PEI. The growth medium was replaced by complete 
DMEM containing different amounts of copolymers cor-
responding to delivery of 1 µg of plasmid. Each concentra-
tion was replicated in three wells. Cells incubated without 
treatment were considered as controls, and cell viability 
values were set at 100%. After incubation for four, eight, 
12, and 24 hours, respectively, the medium was changed 
to normal culture medium. Cells were incubated for another 
48 hours. For cell viability assay, 20 µL of sterile, filtered 
MTT stock solutions in phosphate-buffered saline 
(5 mg/mL) was added to each well. After four hours, the 
unreacted dye was removed, and the formazan crystals were 
dissolved with 150 µL of dimethyl sulfoxide. After gentle 
agitation for five minutes, the absorbance was read at 
570 nm using a DU730 nucleic acid/protein analyzer 
  (Beckman Coulter, Brea, CA).
Wound and healing assay
The rat mesenchymal stem cells were plated on six-well plates 
until they reached a confluence of 80%–90% with complete 
DMEM containing PEG-PEI 14 µg/mL. A cell scraper was 
used to prepare a scratch across the layer of rat mesenchymal 
stem cells, as described previously by Faber-Elman et al.31 
Rat mesenchymal stem cells were incubated at 0, two, four, 
and eight hours after scratching, and the time-dependent 
percentages of the scratched area were calculated.
stem cell differentiation assay
After being incubated in complete DMEM containing 
  PEG-PEI 14 µg/mL, the multilineage differentiation potential 
of the rat mesenchymal stem cells was assessed by testing 
their ability to differentiate into adipocytes and osteoblasts. 
Briefly, adipocyte and osteoblast differentiation was achieved 
after one week of culture of rat mesenchymal stem cells with 
adipogenic and osteogenic medium, respectively (Cyagen 
Biosciences, China). Oil-red-O and silver nitrate were used 
to identify the adipocytes and osteoblasts, respectively.International Journal of Nanomedicine 2011:6
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Figure 1 Fourier transform infrared spectra of polyethylene glycol-grafted poly-
ethylenimine.
Note:  A  strong  absorption  around  1657  cm-1  attributed  to  the  amide  linkage 
appeared, and the strong and broad peak around 3400 cm-1 was attributed to the 
characteristic absorption of amines. These results indicated that polyethylene glycol 
was grafted on to polyethylenimine chains by amide linkage.
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gene transfection experiments
The rat mesenchymal stem cells were seeded in six-well plates 
at a density of 2 × 105 cells per well, and cultured about 24 hours 
before transfection until they reached 70%–80% confluence. 
Plasmid 4 µg was utilized for making a series of N/P ratios. 
The plasmid-encapsulated PEG-PEI complexes were prepared 
at N/P ratios of 0–50, and the cationic liposome (Lipofectamine)/
plasmid complexes were used as controls. Cells were incubated 
for eight hours with each complex. The cells were then washed 
and replated with complete DMEM and incubated at 37°C in 
5% CO2 atmosphere for 48 hours. The expression of pEGFP-C1 
was observed by fluorescence microscopy (Nikon, Tokyo, 
Japan).   Fluorescence was detected using 520 nm and 570 nm 
band pass filters for pEGFP-C1. The transfection efficiency of 
cells expressing pEGFP-C1 was determined using a FACS 
AriaTM System from Becton-Dickinson (San Jose, CA). After 
being photographed by fluorescence microscopy, the cells were 
washed with phosphate-buffered saline and collected with a 
cell scraper and resuspended in phosphate-buffered saline for 
flow cytometry assay. Fluorescence parameters from approxi-
mately 10,000 cells were acquired, and transfection experi-
ments were carried out in triplicate. Data analysis was carried 
out by using the WinMDI program.
Interaction of plasmid-encapsulated  
Peg-PeI and rat mesenchymal stem cells
The rat mesenchymal stem cells were seeded on cover slips 
and incubated with plasmid-encapsulated PEG-PEI for six 
hours. The rat mesenchymal stem cells were then washed 
with phosphate-buffered saline, fixed with 2.5% glutaralde-
hyde for 15 minutes, washed with distilled water, and dried 
at room temperature. The samples were scanned with a 
UL20B silicon probe on atomic force microscopy (Autoprobe 
CP Research, Thermomicroscopes, Goleta, CA) and analyzed 
by atomic force microscopy original software (IP2.1). 
The measurements were carried out in contact mode.
Results and discussion
synthesis and characterization 
of Peg-PeI copolymer
On Fourier transform infrared spectrum analysis of the 
PEG-PEI copolymer (shown in Figure 1), strong absorption 
around 1657 cm-1 appeared and was attributed to amide 
linkage, and a strong and broad peak around 3400 cm-1 was 
attributed to the characteristic absorption of amines. These 
results indicated that polyethylene glycol was grafted onto 
the polyethylenimine chains through amide linkage. 
The 1H-NMR spectrum of the PEG-PEI graft copolymer is 
shown in Figure 2. Strongly characteristic peaks of polyeth-
ylene glycol and polyethylenimine residues at approximately 
3.65 ppm (peak B) and about 2.65 ppm (peaks D and E), 
respectively, were observed. 1H-NMR spectroscopy further 
demonstrated that polyethylenimine was conjugated to the 
polyethylene glycol chains. The graft density of polyethyl-
ene glycol onto polyethylenimine was thus calculated to be 
four from the integral values of peak B and peaks D and E, 
using the known molecular weights of polyethylene glycol 
(2 kDa) and polyethylenimine (25 kDa).
Toxicity and biocompatibility  
of Peg-PeI copolymer
The superior transfection efficiency was based on cell 
  viability. The cytotoxicity of PEG-PEI was related to copo-
lymer concentration and incubation time in the culture 
medium. PEG-PEI showed minimal toxicity below a concen-
tration of 8.75 µg/mL, corresponding to condensed 4 µg DNA 
at an N/P ratio of 25 in the six-well plate. Figure 3 shows the 
influence of rat mesenchymal stem cell viability on PEG-PEI 
concentration and incubation time. The results indicate that 
rat mesenchymal stem cells still maintained high viability 
after being incubated with PEG-PEI 14 µg/mL (corresponding 
to N/P 40) for 4–8 hours. However, cell viability attenuated 
remarkably when the cells were incubated, PEG-PEI concentra-
tion exceeded 14 µg/mL, and incubation time was longer than 
eight hours. Because superior transfection efficiency depends 
on cell viability, cytotoxicity was the main cause of the 
  transfection efficiency decrease at an N/P ratio of 50.International Journal of Nanomedicine 2011:6
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Figure 2 1h-NMr spectrum of Peg-PeI.
Note: Peg-PeI was synthesized by conjugating Peg-Nhs onto polyethylenimine. 1h-NMr analysis of the dialyzed PeI-g-Peg revealed prominent chemical shifts of protons 
from polyethylene glycol (–OCh2Ch2–, 3.65 ppm; Ch3O–, 3.38 ppm) and polyethylenimine (–Ch2Ch2 Nh–, 2.5–2.9 ppm), respectively, indicating that polyethylene glycol 
chains were successfully grafted onto polyethylenimine chains. Polyethylene glycol grafting density of polyethylenimine was 3.8, as characterized by 1h-NMr. 
Abbreviations: 1h-NMr, hydrogen-1 high resolution NMr; Peg-PeI, polyethylene glycol-grafted polyethylenimine; Peg-Nhs, polyethylene glycol-N-hydroxysuccinimide.
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Figure  3  Influence  of  the  viability  of  rat  mesenchymal  stem  cells  on    PEG-PEI 
concentration and incubation time. 
Note: The cells were treated with various concentrations of Peg-PeI for four, eight, 
12, and 24 hours. Cell viability was determined by MTT assay. Incubated with Peg-
PeI 14 µg/mL (corresponding to an N/P ratio of 40) for 4–8 hours, rat mesenchymal 
stem cells maintained high viability. The percentages of viable rat mesenchymal stem 
cells are shown. Values are the mean ± standard deviation (n = 3). 
Abbreviations: Peg-PeI, polyethylene glycol-grafted polyethylenimine; rMsCs, rat 
mesenchymal stem cell.
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We also assessed whether the migration and differentia-
tion ability of stem cells was influenced when they were 
incubated with PEG-PEI. The wound and healing assay 
was designed to simulate the ability of stem cells to recon-
struct a tissue. Rat mesenchymal stem cells incubated with 
culture medium containing PEG-PEI 14 µg/mL for eight 
hours migrated to the scratched area and resettled 
(Figure 4). The migration velocity of rat mesenchymal 
stem cells incubated with PEG-PEI for less than four hours 
did not change significantly compared with those incubated 
with DMEM. This incubation time-dependent regularity 
was consistent with that of the cell viability test. 
  Furthermore, after incubation with PEG-PEI 14 µg /mL 
for eight hours, the rat mesenchymal stem cells were 
induced to differentiate into adipocytes and osteoblasts. 
The N/P ratio of 40 was considered to be safe for stem 
cells of multiple potency for differentiating to adipocytes 
and osteoblasts (Figure 5). In summary, the PEG-PEI 
copolymer exhibited low toxicity and good biocompatibil-
ity at a concentration of 14 µg/mL.
Properties of plasmid-encapsulated  
Peg-PeI nanoparticles
To demonstrate the interaction between the positive PEG-PEI 
and the negative plasmid, a gel retardation assay was per-
formed using electrophoresis. A typical result obtained dur-
ing these electrophoresis experiments for the copolymer is 
presented in Figure 6A. Gel electrophoresis showed that 
PEG-PEI completely bound with plasmid at an N/P ratio 
of 3. Moreover, PEG-PEI condensed plasmid to form stable 
nanoparticles 100–200 nm in diameter at an N/P ratio of 15 
(Figure 6B). In order to obtain nanoparticles effective for 
packing and delivery of plasmid, an N/P ratio .15 was 
chosen. Plasmid-encapsulated PEG-PEI nanoparticles with International Journal of Nanomedicine 2011:6
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Figure 4 Wound and healing assay for rat mesenchymal stem cells.
Note: The confluent cells incubated with complete Dulbecco’s modified Eagle’s medium (A, B, C, D) or culture medium containing Peg-PeI 14 µg/mL (E, F, G, H) were 
scratched by a cell scraper (A, E), and cultured for two (B, F), four (C, G), or eight (D, H) hours. After scratching, the surrounding cells migrated into the scratched area 
(time after scratching is indicated; original magnification × 100). The time-dependent percentages of the residual scratched area were calculated under control conditions and 
in the presence of Peg-PeI 14 µg/mL. When incubated with PEG-PEI for less than four hours, the migration velocity of the rat mesenchymal stem cells displayed insignificant 
changes. Values are the mean ± standard deviation (n = 3 independent experiments). 
*P , 0.05 for rat mesenchymal stem cells incubated with Peg-PeI over four hours versus control group. 
Abbreviation: Peg-PeI, polyethylene glycol-grafted polyethylenimine.
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low toxicity and good compatibility for gene delivery are 
anticipated to achieve a long circulation time in blood.
Gene transfection efficiency of plasmid-
encapsulated Peg-PeI nanoparticles
Mesenchymal stem cells are attractive targets in gene therapy 
for several human diseases. However, their ability to internal-
ize and express exogenous DNA via nonviral gene delivery 
vehicles has been poorly investigated so far. Although the 
feasibility of using liposome and other lipid-based gene 
  carriers32 for transfecting many cell lines has been confirmed, 
there has been little research reported on cationic copolymer 
PEG-PEI-mediated transfection in stem cells. Here, we 
evaluated the transfection efficiency of PEG-PEI for deliver-
ing plasmid to rat mesenchymal stem cells. Passage 2–4 rat 
mesenchymal stem cells were used for the transfection 
experiments. The cationic liposome is a commercial nonviral 
gene delivery reagent and has been commonly used in 
AB
Figure 5 The multilineage potential of rat mesenchymal stem cells after incubation 
with the copolymer. 
Note: After incubating with Peg-PeI 14 µg/mL for eight hours, rat mesenchymal 
stem cells were induced to differentiate into adipocytes (A red cells) and osteoblasts 
(B black cells). Original magnification × 400. 
Abbreviation: Peg-PeI, polyethylene glycol-grafted polyethylenimine.
transfecting many cell lines, so the transfection efficacy of 
cationic liposome was used as a positive control.
Forty-eight hours after transfection, the green fluores-
cence of the enhanced green fluorescent protein (EGFP) was 
observed qualitatively using fluorescence microscopy and International Journal of Nanomedicine 2011:6
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Figure  6  electrophoretic  migration  and  dynamic  diameter  distribution  of 
Peg-PeI/egFP-C1 nanoparticles at various N/P ratios. 
Note: To condense 1 µg DNA, Peg-PeI/pegFP-C1 complexes were prepared at 
a series of N/P ratios. A) Agarose gel electrophoresis image showing that Peg-
PeI completely bound with pegFP-C1 at an N/P ratio of 3. B) Dynamic diameter 
distribution showing that Peg-PeI condensed pegFP-C1 to form nanoparticles in 
the 100–150 nm diameter range at an N/P ratio of 15. The particle diameters of the 
nanoparticles decreased further when the N/P ratio was over 10 and were stable 
when over 20. Values are the mean ± standard deviation (n = 3). 
Abbreviations:  Peg-PeI,  polyethylene  glycol-grafted  polyethylenimine;  egFP, 
enhanced green fluorescent protein.
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Moreover, the increase in the N/P ratio of PEG-PEI to DNA 
resulted in increased gene expression in rat mesenchymal 
stem cells, but the transfection efficacy degraded remarkably 
at an N/P ratio of 50. Considering the cytotoxicity of 
PEG-PEI concentrations above 14 µg/mL, cell death and 
limited cell viability were the main causes of the lower 
transfection efficiency at an N/P ratio of 50.
Our results for the gene transfection efficiency of 
plasmid-encapsulated PEG-PEI nanoparticles is in agree-
ment with that previously reported.33–36 The feasibility of 
using polyethylenimine for transfection of many cell lines, 
in addition to liposomal and other lipid-based carriers, has 
been confirmed,33 but several researchers have demon-
strated that it is difficult for polyethylenimine to obtain 
higher transfection efficiency than a viral vehicle.34–36 
Farrell et al34 reported that the 48-hour transfection effi-
ciency of polyethylenimine-mediated gene delivery to rat 
mesenchymal stem cells is below 4% at an N/P ratio of 7. 
Ahn et al35 reported that introducing DNA/PEI nanoparti-
cles into rat mesenchymal stem cells resulted in 2%–10% 
transfection efficiency. In human adipose-derived stem 
cells, polyethylenimine produced the highest transfection 
of 19% at an N/P ratio of 8, which was superior to that 
achieved by Lipofectamine.36
Cell internalization is correlated with the buffer action 
of the cell membrane reservoir, the functioning of the 
cytoskeleton, and the location of the nanomicrocapsules 
within cells. The interaction between nanomicrocapsules 
and various cell lines may be very different. The mechanical 
properties of stem cells, including cell membrane tension 
and adhesion, and cytoskeleton molding and elasticity, are 
different from those of terminally differentiated cells.37,38 
Moreover, Farrell et al34 found that less than 10% of PEI/
DNA or poly-L-lysine/DNA intake by mesenchymal stem 
cells occurred in the nuclei. It is suggested that relatively 
low gene internalization and expression in rat mesenchymal 
stem cells during cationic polymer-mediated gene delivery 
might be caused by their low uptake capacity and the 
  distinct cytoskeleton mechanism involved in cellular 
trafficking.39
Superior transfection efficiency was obtained at the opti-
mized N/P ratio of 40, which was much more than the N/P 
ratio of 15 needed for stable nanoparticle formation, implying 
that there was much dissociative PEG-PEI in the culture 
medium. Dissociative PEG-PEI did not pack and deliver 
plasmid, but probably enhanced the permeability of the cell 
membrane, activated cell membrane components, and 
  indirectly increased endocytosis.40
flow cytometry. No green fluorescent protein expression on 
naked plasmid was observed under the fluorescence 
  microscope (data not shown), whereas the cationic liposome/
pEGFP-C1 and the PEG-PEI/pEGFP-C1 nanoparticles 
  produced green fluorescent cells after gene transfection 
  (Figures 7A and 7B). In the same area of visual field, the 
number of green fluorescent cells of the PEG-PEI/pEGFP-C1 
nanoparticle group was nearly double than that of the cationic 
liposome/pEGFP-C1 group.
The exact percentages of green fluorescent cells were 
then counted by flow cytometry (Figures 7C and 7D). 
  Transfection efficiencies were compared in the following 
manner: rat mesenchymal stem cells incubated with cationic 
liposome/EGFP-C1 was the control group, and rat mesen-
chymal stem cells incubated with PEG-PEI/EGFP-C1 at N/P 
ratios of 10, 20, 30, 40, and 50 comprised the experimental 
groups. At the optimal N/P ratio of 40, the delivery efficacy 
(15%–21%) of PEG-PEI complexes in rat mesenchymal stem 
cells is higher than the delivery efficacy (8%–15%) of cat-
ionic liposomes. These results suggest that PEG-PEI is a 
valid gene delivery agent and has better transfection efficacy 
in rat mesenchymal stem cells than does the cationic l  iposome. International Journal of Nanomedicine 2011:6
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Figure 7 egFP-C1 encapsulated by different carriers for gene delivery into rat mesenchymal stem cells. 
Note: Fluorescence microscopy was used to observe the transfection efficiency of PEG-PEI-mediated plasmid delivery in rat mesenchymal stem cells. A) Peg-PeI and B) 
liposome. Typical samples of rat mesenchymal stem cells showed 8%–15% egFP expression when incubated with cationic liposome/egFP-C1 (D), and showed 15%–21% 
egFP expression when incubated with Peg-PeI/pegFP-C1 at the optimal N/P ratio of 40 (C). Original magnification × 100. The transfection efficiency tendency of rat 
mesenchymal stem cells incubated with cationic liposome/egFP-C1 or Peg-PeI/egFP-C1 at N/P ratios of 10, 20, 30, 40, and 50 are shown. An increase in the N/P ratio of 
PEG-PEI to DNA resulted in an increase of gene expression in rat mesenchymal stem cells, but the transfection efficacy degraded remarkably at an N/P ratio of 50. Values 
are the mean ± standard deviation (n = 3). 
*P , 0.05 for N/P 40 versus N/P 10, 20, 30, and 50, and cationic liposome. 
Abbreviations: egFP, enhanced green fluorescent protein; FITC, Fluoreceine-isothiocyanate: PEG-PEI, polyethylene glycol-grafted polyethylenimine; rMSCs, rat mesenchymal 
stem cells; ssC, side scatter.
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Interaction of nanoparticles and rat 
mesenchymal stem cells
To highlight the interactions between plasmid-encapsulated 
PEG-PEI microcapsules and the cell membrane, atomic force 
microscopy were used to scan the ultrastructure of rat mes-
enchymal stem cells in the 1–70 µm range. Figures 8A and 
8B showed a typical rat mesenchymal stem cell which is 
fusiform-shaped with a well-arranged cytoskeleton. Although 
some small introcessions can be detected, the surface of the 
nuclear region and the boundary of the cell are relatively 
smooth (Figures 8C and 8D).
After six hours’ incubation of plasmid-encapsulated 
PEG-PEI, nanoparticles 200–400 nm in diameter adsorb onto 
the cell membrane (Figures 8E–8H) by concentrating 
  negatively charged plasmid onto the positively charged 
nanoparticles. Some samples were washed with phosphate-
buffered saline and cultured for another six hours. Some 
biggish hollows were observed (Figures 8I–8L). Compared 
with the pits on the control cells, the hollows are fewer, 
deeper, and presumed to reflect cytophagocytosis of the 
plasmid-encapsulated PEG-PEI nanoparticles (Figures 8M 
and 8N). The interactions between the plasmid-encapsulated 
PEG-PEI and the cytoskeleton of rat mesenchymal stem cells 
will be investigated further in the future. New insights into 
the behavior of nanoparticles might guide improvements in 
vector design for clinical application, such as improved 
interaction with the cytoskeleton by promoting binding of 
motor proteins (see Figure 8).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 8 Cellular uptake of plasmid-encapsulated Peg-PeI microcapsules observed by atomic force microscopy. 
Note: The samples were scanned in the range of 1–70 µm with a UL20B silicon probe on atomic force microscopy and analyzed by original software (IP2.1). The 
measurements were carried out in contact mode. Typical passage 4 rat mesenchymal stem cells comprised the controls (A, B), and the surface of the nuclear region and 
the boundary of the cell are relatively smooth (C, D). After six hours of plasmid-encapsulated Peg-PeI incubation, nanoparticles of 200–400 nm diameter adsorb onto the 
cell membrane (E, F). some samples were washed with phosphate-buffered saline and cultured for another six hours. some biggish hollows can be observed (G, H, I, and J). 
simulation at three dimensions of (I and J) are showed in (K and L) separately.
Abbreviation: Peg-PeI, polyethylene glycol-grafted polyethylenimine.
Conclusion
Our results demonstrate that polyethylenimine modified with 
polyethylene glycol sufficiently condensed plasmid into 
nanoparticles. After optimizing the N/P ratio for plasmid 
delivery, PEG-PEI/pEGFP-C1 nanoparticles displayed low 
cytotoxicity, good solubility, and compatibility with serum. 
The migration velocity and multiple differentiation potency 
of rat mesenchymal stem cells were not affected after expo-
sure to the copolymers during 48 hours of transfection. 
PEG-PEI/DNA at an N/P ratio of 40 obtained the highest 
efficiency (21%) in rat mesenchymal stem cells, which was 
better than for cationic liposomes.
Our data indicate that PEG-PEI is a valid gene vehicle and 
an even better choice for transfecting rat mesenchymal stem 
cells than conventional liposomes. PEG-PEI is a representative 
synthetic gene vector and displays superiority in many situa-
tions. Biocompatibility was guaranteed by dense polyethylene 
glycol shells, which endowed the nanoparticles with water 
solubility and prevented their interaction with serum protein 
in the culture medium. At an optimum N/P ratio, PEG-PEI also 
may have the advantage of lower toxicity and better adsorption 
properties than liposomes. This makes PEG-PEI a promising 
gene vector in vivo, with PEGylation preventing aggregation 
of PEI/DNA complexes under physiological conditions.
Acknowledgments
This work was supported by the Sun Yat-sen University 
Postgraduates’ Training Project, the Yi-xian Innovators’ International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
852
Chen et al
Training Project by Outstanding Mentor(s) at Sun Yat-sen 
University (NO:50000-3126203), the Graduates’ internation-
ally cooperated research project of Sun Yat-sen University 
(2008–2009), the National Natural Science Foundation of 
China, and the Science and Technology Planning Project of 
Guangdong Province, China.
Disclosure
The authors report no conflicts of interest in this work.
References
  1.  Lin Z, Willers C, Xu J, Zheng MH. The chondrocyte: Biology and 
clinical application. Tissue Eng. 2006;12(7):1971–1984.
  2.  Pereira RF, Halford KW, O’Hara MD, et al. Cultured adherent cells 
from marrow can serve as long-lasting precursor cells for bone, carti-
lage, and lung in irradiated mice. Proc Natl Acad Sci. 1995;92(11): 
4857–4861.
  3.  Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. 
  Engraftment and migration of human bone marrow stromal cells 
implanted in the brains of albino rats: Similarities to astrocyte grafts. 
Proc Natl Acad Sci. 1998;95(7):3908–3913.
  4.  Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M. Therapeutic benefit 
of intracerebral transplantation of bone marrow stromal cells after 
cerebral ischemia in rats. J Neurol Sci. 2001;189(1–2):49–57.
  5.  Gou S, Wang C, Liu T, et al. Spontaneous differentiation of murine 
bone marrow-derived mesenchymal stem cells into adipocytes without 
malignant transformation after long-term culture. Cells Tissues Organs. 
2010;191(3):185–192.
  6.  Krebsbach PH, Kuznetsov SA, Bianco P, Robey PG. Bone marrow 
stromal cells: Characterization and clinical application. Crit Rev Oral 
Biol Med. 1999;10(2):165–181.
  7.  Li Y, Chen J, Chen XG, et al. Human marrow stromal cell therapy for 
stroke in rat: Neurotrophins and functional recovery. Neurology. 
2002;59(4):514–523.
  8.  Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate 
allogeneic immune cell responses. Blood. 2005;105(4):1815–1822.
  9.  Wang Y, Deng Y, Zhou GQ. SDF-1alpha/CXCR4-mediated migration 
of systemically transplanted bone marrow stromal cells towards 
ischemic brain lesion in a rat model. Brain Res. 2008;1195: 
104–112.
  10.  Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous admin-
istration of bone marrow stromal cells after cerebral ischemia in rats. 
Stroke. 2001;32(4):1005–1011.
  11.  Dai F, Shi D, He W, et al. hCTLA4-gene modified human bone marrow-
derived mesenchymal stem cells as allogeneic seed cells in bone tissue 
engineering. Tissue Eng. 2006;12(9);2583–2590.
  12.  Bivalacqua TJ, Deng W, Kendirci M, et al. Mesenchymal stem cells 
alone or ex vivo gene modified with endothelial nitric oxide synthase 
reverse age-associated erectile dysfunction. Am J Physiol Heart Circ 
Physiol. 2007;292(3);H1278–H1290.
  13.  Cheng Z, Ou L, Zhou X, et al. Targeted migration of mesenchymal 
stem cells modified with CXCR4 gene to infarcted myocardium 
improves cardiac performance. Mol Ther. 2008;16(3):571–579.
  14.  Breen A, Strappe P, Kumar A, O’Brien T, Pandit A. Optimization 
of a fibrin scaffold for sustained release of an adenoviral gene vector. 
J Biomed Mater Res A. 2006;78(4):702–708.
  15.  Palmer JA, Branston RH, Lilley CE, et al. Development and optimiza-
tion of herpes simplex virus vectors for multiple long-term gene 
delivery to the peripheral nervous system. J Virol. 2000;74(12): 
5604–5618.
  16.  Nimesh S, Kumar R, Chandra R. Novel polyallylamine-dextran sulfate-
DNA nanoplexes: Highly efficient non-viral vector for gene delivery. 
Int J Pharm. 2006;320(1–2):143–149.
  17.  Kim MS, Diamond SL. Controlled release of DNA/polyamine complex 
by photoirradiation of a solid phase presenting o-nitrobenzyl ether 
tethered spermine or polyethyleneimine. Bioorg Med Chem Lett. 2006; 
16(21):5572–5575.
  18.  Su CJ, Liu YC, Chen HL, et al. Two-dimensional densely packed DNA 
nanostructure derived from DNA complexation with a low-generation 
poly(amidoamine) dendrimer. Langmuir. 2007;23(3):975–978.
  19.  Banerjee, P, Weissleder R, Bogdanov AJ. Linear polyethyleneimine 
grafted to a hyperbranched poly(ethylene glycol)-like core: A copoly-
mer for gene delivery. Bioconjug Chem. 2006;17(1):125–131.
  20.  Kleemann E, Neu M, Jekel N, et al. Nano-carriers for DNA delivery 
to the lung based upon a TAT-derived peptide covalently coupled to 
PEG-PEI. J Control Release. 2005;109(1–3):299–316.
  21.  Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polyethyl-
enimine-mediated DNA transfection and the proton sponge hypothesis. 
J Gene Med. 2005;7(5):657–663.
  22.  Brunot C, Ponsonnet L, Lagneau C, Farge P, Picart C, Grosgogeat B. 
Cytotoxicity of polyethyleneimine (PEI), precursor base layer of poly-
electrolyte multilayer films. Biomaterials. 2007;28(4):632–640.
  23.  Zhu W, Chen J, Cong X, Hu S, Chen X. Hypoxia and serum deprivation-
induced apoptosis in mesenchymal stem cells. Stem Cells. 2006; 
24(2):416–425.
  24.  Nguyen HK, Lemieux P, Vinogradov SV , et al. Evaluation of polyether-
polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 
2000;7(2):126–138.
  25.  Wen Y, Pan S, Luo X, Zhang W, Shen Y, Feng M. PEG- and PDMAEG-
graft-modified branched PEI as novel gene vector: Synthesis, charac-
terization and gene transfection. J Biomater Sci Polym Ed. 2010; 
21(8):1103–1126.
  26.  Weiss SI, Sieverling N, Niclasen M, et al. Uronic acids functionalized 
polyethyleneimine (PEI)-polyethyleneglycol (PEG)-graft-copolymers 
as novel synthetic gene carriers. Biomaterials. 2006;27(10): 
2302–2312.
  27.  Merdan T, Kopecek J, Kissel T. Prospects for cationic polymers in gene 
and oligonucleotide therapy against cancer. Adv Drug Deliv Rev. 2002; 
54(5):715–758.
  28.  Kircheis R, Wightman L, Wagner E. Design and gene delivery activity of 
modified polyethylenimines. Adv Drug Deliv Rev. 2001;53(3): 
341–358.
  29.  Ogris M, Brunner S, Schüller S, Kircheis R, Wagner E. PEGylated 
DNA/transferrin-PEI complexes: Reduced interaction with blood 
components, extended circulation in blood and potential for systemic 
gene delivery. Gene Ther. 1999;6(4):595–605.
  30.  Wu Y, Wang W, Chen Y, et al. The investigation of polymer-siRNA 
nanoparticle for gene therapy of gastric cancer in vitro. Int J 
  Nanomedicine. 2010;5:129–136.
  31.  Faber-Elman A, Solomon A, Abraham JA, Marikovsky M, Schwartz 
M. Involvement of wound-associated factors in rat brain astrocyte 
migratory response to axonal injury: In vitro simulation. J Clin Invest. 
1996;97(1):162–171.
  32.  Park J, Ries J, Gelse K, et al. Bone regeneration in critical size defects 
by cell-mediated BMP-2 gene transfer: A comparison of adenoviral 
vectors and liposomes. Gene Ther. 2003;10(13):1089–1098.
  33.  Pochampally RR, Horwitz EM, DiGirolamo CM, Stokes DS, 
Prockop DJ. Correction of a mineralization defect by overexpression 
of a wild-type cDNA for COL1 A1 in marrow stromal cells (MSCs) 
from a patient with osteogenesis imperfecta: A strategy for rescuing 
mutations that produce dominant-negative protein defects. Gene Ther. 
2005;12(14):1119–1125.
  34.  Farrell LL, Pepin J, Kucharski C, Lin X, Xu Z, Uludag H. A comparison 
of the effectiveness of cationic polymers poly-L-lysine (PLL) and 
polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone 
marrow stromal cells (BMSC). Eur J Pharm Biopharm. 2007;65(3): 
388–397.
  35.  Ahn HH, Lee MS, Cho MH, et al. DNA/PEI nano-particles for gene 
delivery of rat bone marrow stem cells. Colloids Surf A Physicochem 
Eng Asp. 2008;313–314.International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology in 
diagnostics, therapeutics, and drug delivery systems throughout the 
biomedical field. This journal is indexed on PubMed Central, MedLine, 
CAS, SciSearch®, Current Contents®/Clinical Medicine, Journal 
Citation Reports/Science Edition, EMBase, Scopus and the Elsevier 
Bibliographic databases. The manuscript management system is 
completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
853
Peg-grafted polyethylenimine nanoparticles
  36.  Ahn HH, Lee JH, Kim KS, et al. Polyethyleneimine-mediated gene 
delivery into human adipose derived stem cells. Biomaterials. 2008; 
29(15):2415–2422.
  37.  Settleman J. Tension precedes commitment – even for a stem cell. 
Mol Cell. 2004;14(2):148–150.
  38.  Thomas CH, Collier JH, Sfeir CS, Healy KE. Engineering gene expres-
sion and protein synthesis by modulation of nuclear shape. Proc Natl 
Acad Sci U S A. 2002;99(4):1972–1977.
  39.  Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal 
stem cells. Cytotherapy. 2003;5(6):485–489.
  40.  Hong S, Leroueil PR, Janus EK, et al. Interaction of polycationic 
polymers with supported lipid bilayers and cells: Nanoscale hole forma-
tion and enhanced membrane permeability. Bioconjug Chem. 
2006;17(3):728–734.